December 17, 2014 4:46 PM ET

Biotechnology

Company Overview of Salmedix Inc.

Company Overview

As of June 14, 2005, Salmedix Inc. was acquired by Cephalon, Inc. Salmedix, Inc., a development stage company, operates as an oncology drug development company. It focuses on the treatment of hematologic malignancies or blood cancers. SDX-105, the company’s lead product candidate is primarily used for the treatment of several blood cancers. Salmedix is conducting Phase II clinical trials for SDX-105 in the U.S. and Canada. Its two other clinical-stage product candidates, SDX-101 and SDX-102, are also in Phase II development. SDX-101 has direct anti-tumor activity and also enhances the activity of traditional chemotherapeutic agents by a previously unrecognized mechanism. SDX-102 is a small m...

9380 Judicial Drive

San Diego, CA 92121

United States

Founded in 2000

37 Employees

Phone:

858-622-5050

Fax:

858-622-5060

Key Executives for Salmedix Inc.

Salmedix Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Diffinity Genomics, Inc. United States
Nextran, Inc. United States
Alector LLC United States
Agradis, Inc. United States
GlycoRegImmune, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Salmedix Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.